Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Sep 28, 2021; 13(9): 283-293
Published online Sep 28, 2021. doi: 10.4329/wjr.v13.i9.283
Published online Sep 28, 2021. doi: 10.4329/wjr.v13.i9.283
Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations
Lavannya Atri, Michael Morgan, Sean Harrell, Wael AlJaroudi, Adam E Berman, Division of Cardiology, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States
Adam E Berman, Division of Health Policy, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States
Adam E Berman, Division of Health Economics and Modeling, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States
Author contributions: Atri L and Morgan M wrote the paper; Harrell S, AlJaroudi W, Berman AE made critical revisions and added content to the manuscript; Berman AE conceived the topic and provided oversight of the writing, editing and submission process.
Conflict-of-interest statement: Authors declare no conflict of interest for this article. This manuscript is not under review elsewhere and there is no prior publication of manuscript contents. The views expressed in this article are solely those of the authors.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lavannya Atri, MS, Division of Cardiology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912, United States. latri@augusta.edu
Received: February 28, 2021
Peer-review started: February 28, 2021
First decision: May 6, 2021
Revised: May 27, 2021
Accepted: August 30, 2021
Article in press: August 30, 2021
Published online: September 28, 2021
Processing time: 210 Days and 1.6 Hours
Peer-review started: February 28, 2021
First decision: May 6, 2021
Revised: May 27, 2021
Accepted: August 30, 2021
Article in press: August 30, 2021
Published online: September 28, 2021
Processing time: 210 Days and 1.6 Hours
Core Tip
Core Tip: Cardiovascular magnetic resonance imaging (CMRI) is a powerful imaging modality used in defining cardiac tissue characterization. As the prevalence and incidence of coronavirus disease 2019 (COVID-19) continues to rise, the utility of CMRI in defining COVID-19 related myocardial damage is growing. This review discusses the impact of CMRI in diagnosing myocardial involvement in acutely ill and recovered COVID-19 patients as well as its implications for patient management.